Overcoming Barriers to Prevention, Care, and Treatment of Hepatitis C in Illicit Drug Users
Open Access
- 15 April 2005
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 40 (s5) , S276-S285
- https://doi.org/10.1086/427441
Abstract
Injection drug use accounts for most of the incident infections with hepatitis C virus (HCV) in the United States and other developed countries. HCV iKeywords
This publication has 123 references indexed in Scilit:
- Poor Validity of Self‐Reported Hepatitis B Virus Infection and Vaccination Status among Young Drug UsersClinical Infectious Diseases, 2004
- Syringe Distribution to Injection Drug Users for Prevention of HIV Infection: Opinions and Practices of Health Care Providers in New York CityClinical Infectious Diseases, 2004
- Drug AddictionNew England Journal of Medicine, 2003
- Office-Based Treatment of Opiate Addiction with a Sublingual-Tablet Formulation of Buprenorphine and NaloxoneNew England Journal of Medicine, 2003
- Hepatitis C and AlcoholJournal of Clinical Gastroenterology, 2003
- Compliance with hepatitis B vaccination in 1175 heroin users and risk factors associated with lack of vaccine responseAddiction, 2002
- Alcohol Use and HIV PharmacotherapyAIDS Research and Human Retroviruses, 2002
- Hepatitis C Prevention ProgramsJournal of Public Health Management & Practice, 2002
- Is It Justifiable to Withhold Treatment for Hepatitis C from Illicit-Drug Users?New England Journal of Medicine, 2001
- Psychiatric Comorbidity in Methadone Maintained PatientsJournal of Addictive Diseases, 1998